Top Biotechnology companies in Sweden by EBIT

This ranking features the top 62 Biotechnology companies in Sweden ranked by EBIT, totaling a EBIT of USD 526.69 M, for June 23, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

1 2

Frequently Asked Questions

Which Biotechnology company in Sweden has the highest EBIT ?

The Biotechnology company in Sweden with the highest EBIT is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 506.25 M.
Which Biotechnology company in Sweden has the lowest EBIT ?

The Biotechnology company in Sweden with the lowest EBIT is Hansa Biopharma AB (publ) (Stockholm Stock Exchange: HNSA.ST) at USD -60.31 M.

What are the top 10 Biotechnology companies in Sweden by EBIT ?

The top 10 Biotechnology companies in Sweden by EBIT are Swedish Orphan Biovitrum AB (publ), Vitrolife AB (publ), Medicover AB (publ), AddLife AB (publ), Vimian Group AB (publ), Camurus AB (publ), BioGaia AB (publ), Biotage AB (publ), RaySearch Laboratories AB (publ) and Xvivo Perfusion AB (publ).
What are the bottom 10 Biotechnology companies in Sweden by EBIT ?

The bottom 10 Biotechnology companies in Sweden by EBIT are Hansa Biopharma AB (publ), BioInvent International AB (publ), Moberg Pharma AB (publ), Oncopeptides AB (publ), Xspray Pharma AB (publ), Boule Diagnostics AB (publ), Alligator Bioscience AB (publ), BioArctic AB (publ), Vicore Pharma Holding AB (publ) and Cantargia AB (publ).